Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-time definition of non-randomness in the distribution of genomic events.
Abel U, Deichmann A, Bartholomae C, Schwarzwaelder K, Glimm H, Howe S, Thrasher A, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Fischer A, Jaeger D, von Kalle C, Schmidt M. Abel U, et al. Among authors: fischer a. PLoS One. 2007 Jun 27;2(6):e570. doi: 10.1371/journal.pone.0000570. PLoS One. 2007. PMID: 17593969 Free PMC article.
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M. Hacein-Bey-Abina S, et al. Among authors: fischer a. N Engl J Med. 2002 Apr 18;346(16):1185-93. doi: 10.1056/NEJMoa012616. N Engl J Med. 2002. PMID: 11961146 Free article. Clinical Trial.
Gene therapy of X-linked severe combined immunodeficiency.
Hacein-Bey-Abina S, Fischer A, Cavazzana-Calvo M. Hacein-Bey-Abina S, et al. Among authors: fischer a. Int J Hematol. 2002 Nov;76(4):295-8. doi: 10.1007/BF02982686. Int J Hematol. 2002. PMID: 12463590 Review.
Gene therapy of X-linked severe combined immunodeficiency.
Cavazzana-Calvo M, Hacein-Bey-Abina S, Fischer A. Cavazzana-Calvo M, et al. Among authors: fischer a. Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):507-9. doi: 10.1097/00130832-200212000-00005. Curr Opin Allergy Clin Immunol. 2002. PMID: 14752333 Review.
LMO2 and gene therapy for severe combined immunodeficiency.
Fischer A, Abina SH, Thrasher A, von Kalle C, Cavazzana-Calvo M. Fischer A, et al. N Engl J Med. 2004 Jun 10;350(24):2526-7; author reply 2526-7. doi: 10.1056/NEJM200406103502422. N Engl J Med. 2004. PMID: 15190153 No abstract available.
Gene therapy for immunodeficiency diseases.
Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. Fischer A, et al. Semin Hematol. 2004 Oct;41(4):272-8. doi: 10.1053/j.seminhematol.2004.07.003. Semin Hematol. 2004. PMID: 15508112 Review.
5,257 results